1-4 of 4
Hai-Xia Zhou
Close
Sort by
Journal Articles

Venetoclax, Cladribine and Cytarabine for the Treatment of Relapse/Refractory Acute Lymphoblastic Leukemia: Interim Analysis of a Phase 2 Trial

Yan-yan Li, Hai-xia Zhou, Si-man Huang, Chao-Ling Wan, Ming-zhu Xu, Wen-jie Gong, Chong-Sheng Qian, De-pei Wu, Haiping Dai, Sheng-Li Xue
Journal: Blood
Blood (2023) 142 (Supplement 1): 1506.
https://doi.org/10.1182/blood-2023-185312
Published: 2023
Journal Articles

Recombinant Human Thrombopoietin Combined with Thrombopoietin Receptor Agonists Can Facilitate the Recovery of Platelet after Allogeneic HSCT

Meng Cheng, Chong-Sheng Qian, Hai-xia Zhou, Mingzhu Xu, Wen-jie Gong, Aining Sun, De-pei Wu, Sheng-Li Xue
Journal: Blood
Blood (2023) 142 (Supplement 1): 5451.
https://doi.org/10.1182/blood-2023-191091
Published: 2023
Journal Articles

Safety and Efficacy of CD22/ CD19 CAR-T and Auto-HSCT “Sandwich” Strategy As Consolidation Therapy for Ph Negative B Cell Acute Lymphoblastic Leukemia

Yan Qiu, Chong-Sheng Qian, Hai-Xia Zhou, Ming-Zhu Xu, Li-Qing Kang, Ai-Ning Sun, De-Pei Wu, Lei Yu, Sheng-Li Xue
Journal: Blood
Blood (2023) 142 (Supplement 1): 3481.
https://doi.org/10.1182/blood-2023-182728
Published: 2023
Journal Articles

Safety and Efficacy of CD22 and CD19 Chimeric Antigen Receptor T Cell Treatment Bridging to Autologous Stem Cell Transplantation As Consolidation Therapy for B-Cell Acute Lymphoblastic Leukemia

Yan Qiu, Chong-Sheng Qian, Hai-Xia Zhou, Ming-Zhu Xu, Li-Qing Kang, Ai-Ning Sun, De-Pei Wu, Lei Yu, Shengli Xue
Journal: Blood
Blood (2022) 140 (Supplement 1): 10337–10338.
https://doi.org/10.1182/blood-2022-164636
Published: 2022